CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 70 filers reported holding CARA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,153,000 | -28.2% | 124,110 | -35.5% | 0.76% | +39.3% |
| Q3 2016 | $1,606,000 | +73.6% | 192,300 | 0.0% | 0.55% | +47.8% |
| Q2 2016 | $925,000 | -22.7% | 192,300 | 0.0% | 0.37% | -25.6% |
| Q1 2016 | $1,196,000 | -63.1% | 192,300 | 0.0% | 0.50% | -45.5% |
| Q4 2015 | $3,242,000 | -27.0% | 192,300 | -38.2% | 0.91% | +7.3% |
| Q3 2015 | $4,444,000 | -34.1% | 311,000 | -43.9% | 0.85% | +33.9% |
| Q2 2015 | $6,740,000 | +142.7% | 554,700 | +100.8% | 0.64% | +142.4% |
| Q1 2015 | $2,777,000 | -3.0% | 276,300 | -3.8% | 0.26% | -4.4% |
| Q4 2014 | $2,862,000 | +18.8% | 287,100 | 0.0% | 0.27% | +10.0% |
| Q3 2014 | $2,409,000 | -56.3% | 287,100 | -11.4% | 0.25% | -47.4% |
| Q2 2014 | $5,513,000 | -9.0% | 323,900 | -0.5% | 0.47% | -4.3% |
| Q1 2014 | $6,056,000 | – | 325,400 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |